Engineered and Proteolytic Antibodies Specific for HIV-1gp 120

Project: Research project

Project Details

Description

Engineered and Proteolytic Antibodies Specific for HIV-1gp 120 Engineered and Proteolytic Antibodies Specific for HIV-1gp 120 Custom-Designing Peptides for Cancer immunotherapy
StatusFinished
Effective start/end date1/7/068/31/09

Funding

  • HHS: National Institutes of Health (NIH): $396,503.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.